Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma
Clinical trial NCT00856050 · COMPLETED
Trial details
- NCT number
- NCT00856050
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2013-01-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.